SOURCE-LINKED INTELLIGENCE

Development of Armored targeted CAR-T cells for immune reset of T cell-mediated autoimmune diseases

CORDIS · observation · Publication date unknown

ng lifelong healthcare costs. In this PoC, we will advance our ground-breaking technology from constitutive to inducible targeted CAR and cargo designs, guided by single-cell multiomics and advanced artificial intelligence. We will validate efficacy and safety in RA and MS murine models, paving the way for IND-enabling studies. This modular platform can be expanded to other autoimmune, neuroinflammatory, and fibrotic diseases, representing a new paradigm of precision immunotherapy where both the CAR and its therapeutic payload can be tailored to the disease context.

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

150000

unit

EUR